Treatment for Gaucher disease by inhibiting microglial phagocytosis-induced neuron death

Combination of microglia activation inhibitor and TNF blocker improve neuronopathic symptoms

Proposals for screening and collaborative research on targets for amyloidosis treatment

Search for compounds that target the ubiquitination pathway of BRI2/BRI3, which is involved in the inhibition of aggregation of IAPP and amyloid-β involved in Alzheimer's disease.

A neuroprotective drug in new bismuth formulation

Project of formulation development from mechanism discovery

Small molecule drug for myotonic dystrophy type 1 (DM1)

JM642, New small molecule targeting expanded CUG repeat RNA recover splicing defects in DM1.

Potent Solubilizer for Low-Solubility Aromatic Compounds and its Use

Solubilizer use for experimental formulation of low-solubility seed/hit compounds to evaluate the in vivo drug potency of such compounds.

Liver organoid model containing human hepatocytes for pharmacokinetic assay

Original method and hepatocyte reproduced hepatobiliary function

Sustained-Release L-DOPA for Parkinson’s Disease